ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS

Clinical trial NCT01709396 · SUSPENDED

Trial details

NCT number: NCT01709396
Sponsor: Ottawa Hospital Research Institute
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Leukemia Myelodysplastic Syndrome

Start date: 2012-01-01
Primary completion: 2016-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.